Flagyl Leggangastíll 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

flagyl leggangastíll 500 mg

sanofi-aventis norge as - metronidazolum inn - leggangastíll - 500 mg

Pevaryl Krem + leggangastíll (10 mg/g + 150 mg) Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

pevaryl krem + leggangastíll (10 mg/g + 150 mg)

trimb healthcare ab - econazolum nítrat; econazolum nítrat - krem + leggangastíll - (10 mg/g + 150 mg)

Pevaryl Depot Krem + leggangastíll (1% + 150 mg) Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

pevaryl depot krem + leggangastíll (1% + 150 mg)

trimb healthcare ab - econazolum nítrat; econazolum nítrat - krem + leggangastíll - (1% + 150 mg)

Pevaryl Depot Leggangastíll 150 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

pevaryl depot leggangastíll 150 mg

trimb healthcare ab - econazolum nítrat - leggangastíll - 150 mg

Canesten Leggangatafla 100 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

canesten leggangatafla 100 mg

bayer ab - clotrimazolum inn - leggangatafla - 100 mg

Canesten Leggangatafla 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

canesten leggangatafla 500 mg

bayer ab - clotrimazolum inn - leggangatafla - 500 mg

Teysuno Evrópusambandið - íslenska - EMA (European Medicines Agency)

teysuno

nordic group b.v. - tegafúri, gimeracil, oteracil - magaæxli - Æxlishemjandi lyf - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.

Prograf Hart hylki 0,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

prograf hart hylki 0,5 mg

astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 0,5 mg

Prograf Hart hylki 1 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

prograf hart hylki 1 mg

astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 1 mg

Prograf Hart hylki 5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

prograf hart hylki 5 mg

astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 5 mg